PCI Synthesis, part of SEQENS CDMO has developed an advanced analytical capability that differentiates us from others in the industry. It’s not only the latest advanced equipment but also the experienced organization we have built that helps to support all of our synthesis programs.
As a leading supplier to the Life Science Industry, PCI Synthesis recognizes the importance of adhering to the highest standards for quality; cooperate to set specifications; develop, validate, and operate robust analytical procedures; sample, test, and control all raw materials, intermediates and final products; analytical support for all manufacturing operations; disposition and distribution of manufactured products and in-house stability program
Move the following:
Our analytical department is fully compliant with CFR Part II and all in process testing, method development, method qualification and method validation are done in house by our experienced team of analysts and analytical development scientists.